ArticleMarine biotechnology (New York, N.Y.)2026
Dietary Myo-Inositol Improves Growth, Antioxidant and Immune Responses in Bisphenol S-Exposed Procambarus clarkii.
Article in Marine biotechnology (New York, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Bisphenol S (BPS) is an emerging environmental contaminant that can disrupt oxidative and immune homeostasis in aquatic organisms, whereas myo-inositol (MI) is a water-soluble nutrient involved in growth and cellular signaling. This study evaluated growth, hepatopancreatic biochemical indices, and stress-related gene transcription in crayfish fed 0 or 1000 mg/kg supplemental MI and chronically exposed to 0-10 µg/L BPS for 6 weeks. Compared with the control group, the BPS group had significantly lower weight gain rate (WGR), specific growth rate (SGR), molting frequency, antioxidant enzyme activities (SOD, CAT, and POD), and immune enzyme activities (ACP, AKP, PO, and LZM), together with higher MDA content (P < 0.05). Compared with the BPS group, the MI + BPS group had significantly higher WGR, SGR, molting frequency, SOD, POD, ACP, and PO activities (P < 0.05). The MI + BPS group also showed higher nrf2 and hmc mRNA levels and lower keap1, bip, ire1, casp3, cytc, jnk, il-6, tnf-α, and nf-κb mRNA levels than the BPS group (P < 0.05). WGR, SGR, molting frequency, and hmc mRNA abundance in the MI + BPS group did not differ significantly from the control group (P > 0.05), the remaining endpoints showed indicator-specific responses. These findings indicate that dietary MI supplementation was associated with improved growth and selected antioxidant and immune indices, as well as altered transcription of genes related to oxidative, endoplasmic-reticulum-stress, inflammatory, and apoptosis-associated responses under BPS exposure. Pathway activation, tissue injury, and apoptosis were not directly assessed.
Indexed as
Identifiers
42640335What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.